André L. Lira
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
André L. Lira has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
Cristina Puy
Department of Biomedical Engineering, Oregon Health and Science University, Portland, Oregon, United States
3 shared publications- Owen J. T. McCarty
Department of Biomedical Engineering, Oregon Health & Science University, Portland, Oregon, USA
3 shared publications - Chih-Jen Yang
Department of Emergency Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan
2 shared publications - Florea Lupu
Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK
2 shared publications Jiaqing Pang
Department of Biomedical Engineering, Oregon Health & Science University, Portland, 97239, USA
2 shared publicationsJoseph E. Aslan
Department of Biomedical Engineering, Oregon Health & Science University, Portland, OR, United States of America; Knight Cardiovascular Institute, Oregon Health & Science University, Portland, OR, United States of America
2 shared publications
Latest Publications
- Open Access
- 25 May 2026
- Published by Elsevier in SSRN Electronic Journal
Methodology for applying the Lambert W function in kinetic studies of coagulation proteases
Proteolytic reaction networks play vital roles in key biological processes like coagulation cascades, complement activation, and inflammatory signaling. However, accurately measuring the protease kinetics within these networks can be challenging. Traditional approaches often rely on measuring only the initial linear phase of the reaction, which can require large amounts of reagents and introduce variability due to subjective selection of early time points. This can reduce reproducibility, particularly when substrate concentrations decrease rapidly during the reaction. To overcome these challenges, we applied a mathematical framework based on the explicit Schnell–Mendoza solution of the integrated Michaelis–Menten equation. By using the Lambert function, this approach allows direct nonlinear fitting of entire reaction time courses without the need for complex root-finding or selecting initial velocities. We also incorporated the Goličnik analytical approximation as a simple and highly accurate alternative. Using representative coagulation proteases including human α-thrombin, factor XIa, and plasma kallikrein, we demonstrated that this method reliably estimates kinetic parameters ( and ), while reducing experimental effort, improving reproducibility, and enhancing analytical transparency. Importantly, the method remains robust under conditions where traditional initial-rate analyses are compromised by substrate depletion or poorly defined linear regions. Overall, this progress-curve approach provides a practical and efficient strategy for studying dynamical proteolytic systems. Beyond coagulation enzymes, the framework may be broadly applicable to enzyme network analysis, assay development, diagnostics, and molecular engineering in complex biological systems.
- 25 May 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessMethodology for applying the Lambert W function in kinetic studies of coagulation proteases
Proteolytic reaction networks play vital roles in key biological processes like coagulation cascades, complement activation, and inflammatory signaling. However, accurately measuring the protease kinetics within these networks can be challenging. Traditional approaches often rely on measuring only the initial linear phase of the reaction, which can require large amounts of reagents and introduce variability due to subjective selection of early time points. This can reduce reproducibility, particularly when substrate concentrations decrease rapidly during the reaction. To overcome these challenges, we applied a mathematical framework based on the explicit Schnell–Mendoza solution of the integrated Michaelis–Menten equation. By using the Lambert function, this approach allows direct nonlinear fitting of entire reaction time courses without the need for complex root-finding or selecting initial velocities. We also incorporated the Goličnik analytical approximation as a simple and highly accurate alternative. Using representative coagulation proteases including human α-thrombin, factor XIa, and plasma kallikrein, we demonstrated that this method reliably estimates kinetic parameters ( and ), while reducing experimental effort, improving reproducibility, and enhancing analytical transparency. Importantly, the method remains robust under conditions where traditional initial-rate analyses are compromised by substrate depletion or poorly defined linear regions. Overall, this progress-curve approach provides a practical and efficient strategy for studying dynamical proteolytic systems. Beyond coagulation enzymes, the framework may be broadly applicable to enzyme network analysis, assay development, diagnostics, and molecular engineering in complex biological systems.
- Open Access
- 27 March 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Molecular basis for inhibition of α-thrombin activity by bacterial lipopolysaccharides
Dysregulation of the coagulation pathway is a hallmark of endotoxemia and Gram-negative sepsis, leading to disseminated intravascular coagulation resulting from aberrant thrombin generation. Bacterial components such as lipopolysaccharides (LPS) have been shown to indirectly contribute to thrombin generation by activating or assembling members of the coagulation cascade in an LPS-chemotype dependent manner. Conversely, studies have shown that LPS may directly inhibit thrombin activity through an undefined mechanism. We studied whether the LPS chemotypes from bacteria including Escherichia coli (O111:B4, O26:B6), Klebsiella pneumoniae , and Pseudomonas aeruginosa bind and regulate thrombin activity. We found that these LPS chemotypes bound thrombin exosites via their polysaccharide regions. Only the E.coli O26:B6 and K.pneumoniae LPS chemotypes induced global structural changes in thrombin. Both the monomeric forms of E.coli O26:B6 and K.pneumoniae LPS chemotypes reduced the catalytic efficiency of thrombin and thrombin-dependent fibrin polymerization in purified systems. The E.coli O26:B6 LPS chemotype retained anticoagulant activity in plasma as an Ca 2+ -stabilized aggregate form. Our data suggests that select LPS chemotypes bind and inhibit the proteolytic activity of thrombin in a manner dependent on their supramolecular state. The heterogeneity of physicochemical properties of bacterial envelope components may contribute to the dysregulation of the coagulation pathway during endotoxemia.
- 27 March 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Open AccessMolecular basis for inhibition of α-thrombin activity by bacterial lipopolysaccharides
Dysregulation of the coagulation pathway is a hallmark of endotoxemia and Gram-negative sepsis, leading to disseminated intravascular coagulation resulting from aberrant thrombin generation. Bacterial components such as lipopolysaccharides (LPS) have been shown to indirectly contribute to thrombin generation by activating or assembling members of the coagulation cascade in an LPS-chemotype dependent manner. Conversely, studies have shown that LPS may directly inhibit thrombin activity through an undefined mechanism. We studied whether the LPS chemotypes from bacteria including Escherichia coli (O111:B4, O26:B6), Klebsiella pneumoniae , and Pseudomonas aeruginosa bind and regulate thrombin activity. We found that these LPS chemotypes bound thrombin exosites via their polysaccharide regions. Only the E.coli O26:B6 and K.pneumoniae LPS chemotypes induced global structural changes in thrombin. Both the monomeric forms of E.coli O26:B6 and K.pneumoniae LPS chemotypes reduced the catalytic efficiency of thrombin and thrombin-dependent fibrin polymerization in purified systems. The E.coli O26:B6 LPS chemotype retained anticoagulant activity in plasma as an Ca 2+ -stabilized aggregate form. Our data suggests that select LPS chemotypes bind and inhibit the proteolytic activity of thrombin in a manner dependent on their supramolecular state. The heterogeneity of physicochemical properties of bacterial envelope components may contribute to the dysregulation of the coagulation pathway during endotoxemia.
- 7 October 2025
- Published by Georg Thieme Verlag KG in Seminars in Thrombosis and Hemostasis
- Vol. 52 (06) , 683-691
Lipopolysaccharide and Coagulation Factor XII: Biophysics of Contact Activation in Infection
Lipopolysaccharide (LPS), a key component of the outer membrane of Gram-negative bacteria, is well-known for its role in triggering inflammation via innate immune receptors. However, evidence suggests that LPS can influence coagulation, in part through activation of the contact pathway. Recent studies from our group and others demonstrate that the supramolecular organization and physicochemical properties of LPS—such as aggregate size, surface charge, and chemotype—critically determine the ability of LPS to activate coagulation factor XII (FXII). While monomeric LPS can modulate FXII activity, only aggregated forms of LPS (e.g., micelles) function as a procoagulant surface, initiating contact activation. This review synthesizes current knowledge on LPS structural heterogeneity and explores how the biophysical properties of LPS govern supramolecular assembly in aqueous environments, ultimately dictating interactions with the contact activation pathway. We further discuss the possible mechanisms by which LPS-driven FXII activation contributes to thromboinflammatory disorders, including disseminated intravascular coagulation and sepsis-associated vascular leakage. Finally, we highlight novel therapeutic strategies—from FXIIa inhibitors to molecules that disrupt LPS supramolecular structures—as potential interventions to mitigate coagulation-driven pathology during bacterial infections. These insights not only reflect our growing understanding of infection-associated thrombosis but may also pave the way for targeted therapies in sepsis and other thromboinflammatory conditions.
- 7 October 2025
- Published by Georg Thieme Verlag KG in Seminars in Thrombosis and Hemostasis
- Vol. 52 (06) , 683-691
Lipopolysaccharide and Coagulation Factor XII: Biophysics of Contact Activation in Infection
Lipopolysaccharide (LPS), a key component of the outer membrane of Gram-negative bacteria, is well-known for its role in triggering inflammation via innate immune receptors. However, evidence suggests that LPS can influence coagulation, in part through activation of the contact pathway. Recent studies from our group and others demonstrate that the supramolecular organization and physicochemical properties of LPS—such as aggregate size, surface charge, and chemotype—critically determine the ability of LPS to activate coagulation factor XII (FXII). While monomeric LPS can modulate FXII activity, only aggregated forms of LPS (e.g., micelles) function as a procoagulant surface, initiating contact activation. This review synthesizes current knowledge on LPS structural heterogeneity and explores how the biophysical properties of LPS govern supramolecular assembly in aqueous environments, ultimately dictating interactions with the contact activation pathway. We further discuss the possible mechanisms by which LPS-driven FXII activation contributes to thromboinflammatory disorders, including disseminated intravascular coagulation and sepsis-associated vascular leakage. Finally, we highlight novel therapeutic strategies—from FXIIa inhibitors to molecules that disrupt LPS supramolecular structures—as potential interventions to mitigate coagulation-driven pathology during bacterial infections. These insights not only reflect our growing understanding of infection-associated thrombosis but may also pave the way for targeted therapies in sepsis and other thromboinflammatory conditions.
- Open Access
- 5 July 2025
- Published by Elsevier in Blood Vessels, Thrombosis & Hemostasis
- Vol. 2 (4) , 100091
Bacterial infection and activation of the contact pathway of coagulation
- 5 July 2025
- Published by Elsevier in Blood Vessels, Thrombosis & Hemostasis
- Vol. 2 (4) , 100091
Open AccessBacterial infection and activation of the contact pathway of coagulation
- 6 February 2025
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Biomembranes
- Vol. 1867 (3) , 184415
Lipopolysaccharide supramolecular organization regulates the activation of coagulation factor XII
- 6 February 2025
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Biomembranes
- Vol. 1867 (3) , 184415
Lipopolysaccharide supramolecular organization regulates the activation of coagulation factor XII
- Open Access
- 18 December 2024
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 301 (1) , 108110
The physicochemical properties of lipopolysaccharide chemotypes regulate activation of the contact pathway of blood coagulation
- 18 December 2024
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 301 (1) , 108110
Open AccessThe physicochemical properties of lipopolysaccharide chemotypes regulate activation of the contact pathway of blood coagulation